Join
Live feed
·
PRReleasevia Quantisnow
Scholar Rock Holding Corporation logo

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin

ByQuantisnow·Wall Street's wire, on your screen.
SRRK· Scholar Rock Holding Corporation
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRRK (Scholar Rock Holding Corporation) and more on Quantisnow.